ERVW-1 and myeloid sarcoma: Thus, due to the lack of medical records of MS patients, we were not able to compare the anti‐HERV‐K, anti‐HERV‐W, and anti‐MOG concentration with the type of MS or expanded disability status scale (EDSS).